Effect of Endovascular Thrombectomy for Femoral Popliteal Vein Thrombosis on Venous Valve Function Maintenance: a Single-center, Single-arm Prospective Observational Study
Status: Enrolling by invitation
Location: See all (7) locations...
Intervention Type: Other, Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
To evaluate the venous valvular function after pharmacomechanical thrombectomy (PMT) for acute femoral-popliteal venous thrombosis.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: No
View:
• Patients with acute symptomatic proximal DVT involving the femoral, and/or popliteal vein, common femoral vein, iliac veins (with or without other involved ipsilateral veins) were enrolled at seven vascular centers in China. Patients were treated with PCDT via Zelante device (Boston Scientific).
Locations
Other Locations
China
Chuzhou People's Hospital
Chuzhou
Center hospital of Putu
Shanghai
Central Hospital of Songjiang
Shanghai
Fengchen Hospital
Shanghai
North Branch of Shanghai Ninth People's Hospital
Shanghai
Shanghai Ninth People's Hospital
Shanghai
Taizhou Municipal hospital
Taizhou
Time Frame
Start Date: June 6, 2022
Estimated Completion Date: June 6, 2025
Participants
Target number of participants: 100
Treatments
Experimental: Pharmacomechanical Catheter-directed Thrombolysis for acute DVT
AngioJet, Boston Scientific
Placebo Comparator: anticoagulation alone for acute DVT
anticoagulation alone for acute DVT
Authors
Related Therapeutic Areas
Sponsors
Collaborators: Boston Scientific Corporation
Leads: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University